Guardant Health
GH
#3106
Rank
C$5.62 B
Marketcap
$45.50
Share price
1.73%
Change (1 day)
25.47%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2024 (TTM): -C$0.69 Billion

According to Guardant Health 's latest financial reports the company's current earnings are C$0.69 Billion. In 2023 the company made an earning of -C$0.69 Billion, an increase over its 2022 earnings that were of -C$0.94 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.69 Billion0.28%
2023 -C$0.69 Billion-26.73%
2022 -C$0.94 Billion69.96%
2021 -C$0.56 Billion56.35%
2020 -C$0.36 Billion252.69%
2019 -C$0.11 Billion-17.22%
2018 -C$0.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.31 Billion-58.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$45.37 Million-93.84%๐Ÿ‡บ๐Ÿ‡ธ USA